HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hain rebuked by NASDAQ

This article was originally published in The Rose Sheet

Executive Summary

Staff determination letter sent by NASDAQ Nov. 14 states that Hain Celestials is not in compliance with filing requirements for continued listing due to its failure to timely file Form 10-Q for the fiscal period ended Sept. 30, 2007, firm announces Nov. 16. An independent review of the company's stock option practices, launched last September, is "substantially complete" but has delayed the filing of the 10-Q, as well as its Annual Report on Form 10-K for the year ended June 30, 2007 (1"The Rose Sheet" Sept. 24, 2007, In Brief). Hain shares remain listed on NASDAQ pending a decision from its Listing Qualifications Panel, with which the company met Oct. 31. Any adjustments that have been identified in its review will not affect the company's previously released results of operations for the fiscal year or quarter in question, the firm says...

You may also be interested in...



Hain filing delay

Hain Celestials has requested a hearing before a NASDAQ Listing Qualifications Panel to request continued listing on the stock market, the firm announces Sept. 20. On Sept. 14, the natural-food and personal-care company received a staff determination letter indicating that Hain is not in compliance with NASDAQ filing requirements due to a delay in filing Form 10-K. Hain shares will continue to be listed on NASDAQ pending a decision by the Listing Qualifications Panel. Hain says it is conducting a review of its stock-option practices under the direction of "a group of independent investors" and independent legal counsel. "The timing of that completion has resulted in a delay in finalizing the company's annual report on form 10-K," Hain says. Company notes that the results of the review and any changes recommended by reviewers will not affect its Q4 and FY 2007 results...

E.l.f. Puts Premium On ‘Clean Beauty’ With First Strategic Acquisition: W3ll People

W3ll People is expected to add a relatively modest $7m to e.l.f. Beauty’s fiscal 2021 top line, but the brand has “major white space” opportunities, including at Target, e.l.f.’s longest-standing customer. Further, its plant-based product line includes 40 “EWG Verified” products, reflecting expertise e.l.f. is eager to tap.

UCB Pins Growth Hopes On Burgeoning Late-Stage Pipeline

UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.

 

UsernamePublicRestriction

Register

RS015093

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel